JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

B2157 Cabazitaxel

3 Citation

Target: Microtubule/Tubulin

Summary: Microtubule associated inhibitor

≥22.3 mg/mL
B1162 FRAX597

1 Citation

Target: PAK

Summary: PAK inhibitor,potent and ATP-competitive

≥27.9 mg/mL
A3008 Y-27632 dihydrochloride

19 Citation

Target: ROCK

Summary: ROCK1 inhibitor

≥111.2 mg/mL
A4127 GSK1070916

Target: Aurora Kinases

Summary: Aurora B/C inhibitor

≥25.4 mg/mL
A3188 ARRY-520 R enantiomer

Target: Ksp

Summary: KSP inhibitor

Soluble in DMSO
B4787 SF1670

Target: PTEN

Summary: PTEN inhibitor, potent and specific

insoluble in EtOH; insoluble in H2O; ≥15.37 mg/mL
A8642 R547

2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK1/2/4 inhibitor,ATP-competitive

Soluble in DMSO
A8326 AZD-5438

2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK1/2/9 inhibitor

insoluble in H2O; ≥18.55 mg/mL
A1794 LY2835219

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor,potent and selective

≥30.15 mg/mL
A5919 AZD7762

Target: Chk

Summary: Checkpoint kinase inhibitor,ATP competitive

insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL